Infectious complications in pediatric allogeneic hematopoietic stem cell transplantation recipients-A retrospective clinical and epidemiological cohort study.

Transplant Infectious Disease : an Official Journal of the Transplantation Society
Tyane de Almeida PintoSonia Mara Raboni

Abstract

Hematopoietic stem cell transplantation (HSCT) is an important therapeutic strategy for several hematologic diseases. In the absence of a matched related donor, allogeneic HSCT has been associated with increased risk of infectious complications. Here, we present the clinical and epidemiological characteristics of early infectious complications in children undergoing HSCT from Southern Brazil. This is a retrospective unicentric cohort study of infections in all children receiving their first HSCT during the period between 2010 and 2017. Data from 292 patients were analyzed; bone marrow failures (52.7%) comprised most of the baseline diagnosis. Bone marrow (BM) was the stem cell source in 254 (87%), followed by cord blood (CB) in 34 (11.6%) children. The use of alternative donors (77.8%) and presence of acute graft-vs-host disease (GVHD) (23.6%) were associated with an increased risk of viral and fungal infection. Bacterial infection was observed in 79 patients (27%); 220 patients (75.3%) were diagnosed with viral infection, and 35 patients (12%) developed fungal infection. The presence of fungal disease together with the presence of multiple infections during follow-up was associated with an increased risk of death (P < .001). T...Continue Reading

References

May 15, 2002·The Pediatric Infectious Disease Journal·Daniel Kelly BenjaminPaul Langlie Martin
Dec 20, 2007·Critical Care Medicine·Susan L BrattonHeather T Keenan
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Jan 18, 2011·Hematology/oncology Clinics of North America·John R WingardJohn W Hiemenz
Jan 25, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of America
Jun 1, 2011·Critical Care Nursing Clinics of North America·Julie A KolinsVictor M Aquino
Sep 13, 2012·Current Infectious Disease Reports·Defne Arslan, Lara Danziger-Isakov
Sep 27, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M NucciA L Colombo
Sep 17, 2013·Pediatric Blood & Cancer·Gal GoldsteinAmos Toren
Nov 22, 2013·Transplant Infectious Disease : an Official Journal of the Transplantation Society·A SrinivasanR T Hayden
Feb 5, 2015·Infectious Diseases·Tiffany Simms-WaldripTheodore Moore
Mar 16, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Carmem BonfimRicardo Pasquini
Jul 2, 2016·Haematologica·Jan StyczynskiUNKNOWN Sixth European Conference on Infections in Leukemia, a joint venture of the Infectious Diseases Working Party of the Europea
Sep 23, 2016·Journal of Pediatric Hematology/oncology·Catherine AftandilianRajni Agarwal
Mar 11, 2017·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·A Van EyssenA Davidson
Feb 7, 2018·Infectious Disease Clinics of North America·Monica I Ardura
Sep 20, 2018·American Journal of Infection Control·Andrew W DickPatricia W Stone

❮ Previous
Next ❯

Citations

Jan 30, 2021·Pediatric Transplantation·Tyane de Almeida Pinto JardimSonia Mara Raboni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.